Rita J Desai

Array ( [id] => 4960637 [patent_doc_number] => 20080275062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 10/597473 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12705 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275062.pdf [firstpage_image] =>[orig_patent_app_number] => 10597473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912926 [patent_doc_number] => 20050176684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Novel aryl fructose-1,6-bisphosphatase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/043859 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40449 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176684.pdf [firstpage_image] =>[orig_patent_app_number] => 11043859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200678 [patent_doc_number] => 20050165032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/041174 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13525 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165032.pdf [firstpage_image] =>[orig_patent_app_number] => 11041174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200678 [patent_doc_number] => 20050165032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/041174 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13525 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165032.pdf [firstpage_image] =>[orig_patent_app_number] => 11041174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051336 [patent_doc_number] => 20050187223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Substituted heterocyclic compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/041151 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32196 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187223.pdf [firstpage_image] =>[orig_patent_app_number] => 11041151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181020 [patent_doc_number] => 20050124641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/039702 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11507 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124641.pdf [firstpage_image] =>[orig_patent_app_number] => 11039702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138407 [patent_doc_number] => 20050182073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => '5-Phenylpyrimidines' [patent_app_type] => utility [patent_app_number] => 11/039273 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15860 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182073.pdf [firstpage_image] =>[orig_patent_app_number] => 11039273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750144 [patent_doc_number] => 07022718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Pyridine and pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 11/037989 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12888 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022718.pdf [firstpage_image] =>[orig_patent_app_number] => 11037989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111775 [patent_doc_number] => 20050209231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Compositions and methods for inducing cardiomyogenesis' [patent_app_type] => utility [patent_app_number] => 11/035708 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11979 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209231.pdf [firstpage_image] =>[orig_patent_app_number] => 11035708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853029 [patent_doc_number] => 07378413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => '2-amino-3-(alkyl)-pyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 11/035264 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8667 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378413.pdf [firstpage_image] =>[orig_patent_app_number] => 11035264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005560 [patent_doc_number] => 20070203132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Triazole derivatives which inhibit vasopressin antagonistic activity' [patent_app_type] => utility [patent_app_number] => 10/588876 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15634 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203132.pdf [firstpage_image] =>[orig_patent_app_number] => 10588876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92276 [patent_doc_number] => 07732444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => '2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/032299 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68940 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732444.pdf [firstpage_image] =>[orig_patent_app_number] => 11032299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423014 [patent_doc_number] => 20090149469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors' [patent_app_type] => utility [patent_app_number] => 10/584828 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13268 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149469.pdf [firstpage_image] =>[orig_patent_app_number] => 10584828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24018 [patent_doc_number] => 07795270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'DUTPase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/585283 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20916 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795270.pdf [firstpage_image] =>[orig_patent_app_number] => 10585283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703015 [patent_doc_number] => 08088769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Cyanopyrimidinones' [patent_app_type] => utility [patent_app_number] => 10/586501 [patent_app_country] => US [patent_app_date] => 2004-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15722 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088769.pdf [firstpage_image] =>[orig_patent_app_number] => 10586501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188242 [patent_doc_number] => 20050192291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 11/021042 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68669 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192291.pdf [firstpage_image] =>[orig_patent_app_number] => 11021042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4444743 [patent_doc_number] => 07863220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Herbicidal pyrimidines' [patent_app_type] => utility [patent_app_number] => 10/581897 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56424 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863220.pdf [firstpage_image] =>[orig_patent_app_number] => 10581897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120697 [patent_doc_number] => 20070142412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Crystalline form of 2-{4-[\'3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl}-2-oxoethanol' [patent_app_type] => utility [patent_app_number] => 10/583460 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8699 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142412.pdf [firstpage_image] =>[orig_patent_app_number] => 10583460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237199 [patent_doc_number] => 20070129356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Mitotic kinesin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/582826 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14361 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129356.pdf [firstpage_image] =>[orig_patent_app_number] => 10582826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772697 [patent_doc_number] => 20080058356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => '2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 10/582704 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57944 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058356.pdf [firstpage_image] =>[orig_patent_app_number] => 10582704 [rel_patent_id] =>[rel_patent_doc_number] =>)